Ml. Favier et al., EFFECT OF CYCLODEXTRIN ON PLASMA-LIPIDS AND CHOLESTEROL-METABOLISM INTHE RAT, Metabolism, clinical and experimental, 44(2), 1995, pp. 200-206
beta-Cyclodextrin (beta-CD) is a bile acid and sterol sequestrant prod
uced by enzymatic modification of starch; this product has the potenti
al to decrease plasma cholesterol. In contrast to the sequestrants hav
ing resin- or saponin-like properties, beta-CD is rapidly broken down
by the large intestine microflora. beta-CD effects on cecal fermentati
ons and lipid metabolism were thus investigated in rats adapted to sem
ipurified diets containing 0%, 2.5%, or 5% beta-CD. in rats fed beta-C
D diets, there was an enlargement of the cecum together with a dramati
c increase in the cecal concentration of propionic acid (even with the
2.5% level, in moderately acidic pH conditions). Propionic acid produ
ced in the cecum was readily absorbed and entirely taken up by the liv
er, whereas there was no significant acetic acid uptake. Dietary beta-
CD was highly effective in enhancing bile acid entry into to the cecum
: the cecal bile acids pool was 2.2- and 3.6-fold enlarged in rats fed
the 2.5% and 5% beta-CD diets, respectively. The solubility percentag
e of bile acids decreased to approximately 25% in rats fed the beta-CD
diets (v 51% in controls); the cecal concentration of soluble bile ac
ids was thus relatively low in these animals. The fecal excretion of s
teroids was strongly enhanced by beta-CD, and bile acids excretion was
practically proportional to the dietary beta-CD level. There was a ne
t lipid-lowering effect of beta-CD, even at the 2.5% level. The effect
was more pronounced on triglycerides than on cholesterol. Hypocholest
erolemia corresponded to a decrease of very-low-density lipoprotein (V
LDL), low-density lipoprotein (LDL), and high-density lipoprotein 1 (H
DL(1)) cholesterol, whereas HDL(2) cholesterol was unchanged. In paral
lel, there was an induction of microsomal hydroxymethyl glutaryl coenz
yme A (HMG CoA) reductase, also proportional to the dietary beta-CD le
vel. In conclusion, beta-CD appears to be an effective lipid-lowering
agent due to its bile acid-sequestrant properties. The production of s
hort-chain fatty acids (SCFA) from beta-CD by the large intestine micr
oflora probably plays a minor role in its effects on lipid metabolism.
Nevertheless, by acidifying the large intestine content and solubiliz
ing Ca, cecal SCFA contribute to inhibit the passive reabsorption of b
ile acids. Copyright (C) 1995 by W.B. Saunders Company